Activating transcription factor-2 (ATF2) is a key determinant of resistance to endocrine treatment in an in vitro model of breast cancer
Crossref DOI link:
Update policy: https://doi.org/10.1007/SPRINGER_CROSSMARK_POLICY
Malki, Mohammed Imad
Carroll, Jason S.
Text and Data Mining valid from 2020-11-16
Version of Record valid from 2020-11-16
14 April 2020
20 October 2020
16 November 2020
Ethics approval and consent to participate
The authors declare no competing interests.